Segment disclosures

Company overview

IQVIA HOLDINGS INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

36 dimension combinations 752 retained observations 30 reported periods Partial retained history

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Commercial Solutions

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301793000000 USD20260728Open filing evidence
2026-01-01 – 2026-03-311754000000 USD20260505Open filing evidence
2025-04-01 – 2025-06-301651000000 USD20260728Open filing evidence
2025-01-01 – 2025-03-311572000000 USD20260505Open filing evidence

Operating Segments · Contract Sales And Medical Solutions

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-31788000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-30209000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-30188000000 USD20250722Open filing evidence
2025-01-01 – 2025-03-31181000000 USD20250506Open filing evidence
2024-01-01 – 2024-12-31718000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-30180000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-30172000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-31189000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31727000000 USD20260217Open filing evidence
2022-01-01 – 2022-12-31743000000 USD20250213Open filing evidence
2021-01-01 – 2021-12-31784000000 USD20230215Open filing evidence
2020-01-01 – 2020-12-31741000000 USD20230215Open filing evidence
2019-01-01 – 2019-12-31814000000 USD20210212Open filing evidence
2019-07-01 – 2019-09-30208000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence
2019-01-01 – 2019-09-30604000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence
2019-04-01 – 2019-06-30203000000 USD2019-07-24 · 21:23:44.000ZOpen filing evidence
2019-01-01 – 2019-06-30396000000 USD2019-07-24 · 21:23:44.000ZOpen filing evidence

Operating Segments · Research And Development Solutions

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-302575000000 USD20260728Open filing evidence
2026-01-01 – 2026-03-312397000000 USD20260505Open filing evidence
2025-01-01 – 2025-12-318896000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-302260000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-302366000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-03-312257000000 RestatedUSD20260505Open filing evidence
2024-01-01 – 2024-12-318527000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-302162000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-302147000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-312095000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-318395000000 USD20260217Open filing evidence
2022-01-01 – 2022-12-317921000000 USD20250213Open filing evidence
2021-01-01 – 2021-12-317556000000 USD20230215Open filing evidence
2020-01-01 – 2020-12-315760000000 USD20230215Open filing evidence
2019-01-01 – 2019-12-315788000000 USD20220216Open filing evidence
2019-07-01 – 2019-09-301466000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence
2019-01-01 – 2019-09-304317000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence
2019-04-01 – 2019-06-301435000000 USD2019-07-24 · 21:23:44.000ZOpen filing evidence
2019-01-01 – 2019-06-302851000000 USD2019-07-24 · 21:23:44.000ZOpen filing evidence

Operating Segments · Technology And Analytics Solutions

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-316626000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-301631000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-301628000000 USD20250722Open filing evidence
2025-01-01 – 2025-03-311546000000 USD20250506Open filing evidence
2024-01-01 – 2024-12-316160000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-301554000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-301495000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-311453000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-315862000000 USD20260217Open filing evidence
2022-01-01 – 2022-12-315746000000 USD20250213Open filing evidence
2021-01-01 – 2021-12-315534000000 USD20230215Open filing evidence
2020-01-01 – 2020-12-314858000000 USD20230215Open filing evidence
2020-01-01 – 2020-03-311117000000 USD20200430Open filing evidence
2019-01-01 – 2019-12-314486000000 USD20210212Open filing evidence
2019-07-01 – 2019-09-301095000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence
2019-01-01 – 2019-09-303272000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence
2019-04-01 – 2019-06-301102000000 USD2019-07-24 · 21:23:44.000ZOpen filing evidence
2019-01-01 – 2019-06-302177000000 USD2019-07-24 · 21:23:44.000ZOpen filing evidence

Americas · Commercial Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30895000000 USD20260728Open filing evidence
2026-01-01 – 2026-03-31856000000 USD20260505Open filing evidence
2025-04-01 – 2025-06-30825000000 USD20260728Open filing evidence
2025-01-01 – 2025-03-31790000000 USD20260505Open filing evidence

Americas · Contract Sales And Medical Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-31277000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-3070000000 USD20251028Open filing evidence
2025-01-01 – 2025-09-30208000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-3068000000 USD20250722Open filing evidence
2025-01-01 – 2025-06-30138000000 USD20250722Open filing evidence
2025-01-01 – 2025-03-3170000000 USD20250506Open filing evidence
2024-01-01 – 2024-12-31280000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-3072000000 USD20251028Open filing evidence
2024-01-01 – 2024-09-30211000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-3066000000 USD20250722Open filing evidence
2024-01-01 – 2024-06-30139000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-3173000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31304000000 USD20260217Open filing evidence
2023-07-01 – 2023-09-3078000000 USD20241031Open filing evidence
2023-01-01 – 2023-09-30228000000 USD20241031Open filing evidence
2023-04-01 – 2023-06-3070000000 USD20240722Open filing evidence
2023-01-01 – 2023-06-30150000000 USD20240722Open filing evidence
2023-01-01 – 2023-03-3180000000 USD20230428Open filing evidence
2022-01-01 – 2022-12-31354000000 USD20250213Open filing evidence
2022-04-01 – 2022-06-3088000000 USD20230801Open filing evidence
2022-01-01 – 2022-06-30179000000 USD20230801Open filing evidence
2022-01-01 – 2022-03-3191000000 USD20230428Open filing evidence
2021-07-01 – 2021-09-3094000000 USD20211022Open filing evidence
2021-01-01 – 2021-09-30258000000 USD20211022Open filing evidence
2021-04-01 – 2021-06-3086000000 USD20220722Open filing evidence
2021-01-01 – 2021-06-30164000000 USD20220722Open filing evidence
2021-01-01 – 2021-03-3178000000 USD20220428Open filing evidence
2020-01-01 – 2020-12-31326000000 USD20210212Open filing evidence
2020-07-01 – 2020-09-3076000000 USD20211022Open filing evidence
2020-01-01 – 2020-09-30247000000 USD20211022Open filing evidence
2020-04-01 – 2020-06-3080000000 USD20210728Open filing evidence
2020-01-01 – 2020-06-30171000000 USD20210728Open filing evidence
2019-01-01 – 2019-12-31399000000 USD20210212Open filing evidence

Americas · Research And Development Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301144000000 USD20260728Open filing evidence
2026-01-01 – 2026-06-302272000000 USD20260728Open filing evidence
2026-01-01 – 2026-03-311128000000 USD20260505Open filing evidence
2025-01-01 – 2025-12-314105000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-301039000000 USD20251028Open filing evidence
2025-01-01 – 2025-09-303030000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-301110000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-06-302127000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-03-311017000000 RestatedUSD20260505Open filing evidence
2024-01-01 – 2024-12-313894000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-30969000000 USD20251028Open filing evidence
2024-01-01 – 2024-09-302969000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-301014000000 USD20250722Open filing evidence
2024-01-01 – 2024-06-302000000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-31986000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-314157000000 USD20260217Open filing evidence
2023-07-01 – 2023-09-301017000000 USD20241031Open filing evidence
2023-01-01 – 2023-09-302982000000 USD20241031Open filing evidence
2023-04-01 – 2023-06-30979000000 USD20230801Open filing evidence
2023-01-01 – 2023-06-301965000000 USD20230801Open filing evidence
2023-01-01 – 2023-03-31986000000 USD20240502Open filing evidence
2022-01-01 – 2022-12-313747000000 USD20250213Open filing evidence
2022-07-01 – 2022-09-30960000000 USD20221027Open filing evidence
2022-01-01 – 2022-09-302772000000 USD20221027Open filing evidence
2022-04-01 – 2022-06-30866000000 USD20230801Open filing evidence
2022-01-01 – 2022-06-301812000000 USD20230801Open filing evidence
2022-01-01 – 2022-03-31946000000 USD20220428Open filing evidence
2021-01-01 – 2021-12-313887000000 USD20230215Open filing evidence
2021-07-01 – 2021-09-30942000000 USD20221027Open filing evidence
2021-01-01 – 2021-09-302911000000 USD20221027Open filing evidence
2021-04-01 – 2021-06-30935000000 USD20220722Open filing evidence
2021-01-01 – 2021-06-301969000000 USD20220722Open filing evidence
2021-01-01 – 2021-03-311034000000 USD20220428Open filing evidence
2020-01-01 – 2020-12-312680000000 USD20230215Open filing evidence
2020-07-01 – 2020-09-30628000000 USD20211022Open filing evidence
2020-01-01 – 2020-09-301826000000 USD20211022Open filing evidence
2020-04-01 – 2020-06-30528000000 USD20210728Open filing evidence
2020-01-01 – 2020-06-301198000000 USD20210728Open filing evidence
2019-01-01 – 2019-12-312693000000 USD20220216Open filing evidence
2019-07-01 – 2019-09-30726000000 USD20201022Open filing evidence
2019-01-01 – 2019-09-302009000000 USD20201022Open filing evidence

Americas · Technology And Analytics Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-06-301751000000 USD20260728Open filing evidence
2025-01-01 – 2025-12-313363000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-30824000000 USD20251028Open filing evidence
2025-01-01 – 2025-09-302437000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-30830000000 USD20250722Open filing evidence
2025-01-01 – 2025-06-301615000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-03-31783000000 USD20250506Open filing evidence
2024-01-01 – 2024-12-313182000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-30797000000 USD20251028Open filing evidence
2024-01-01 – 2024-09-302323000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-30783000000 USD20250722Open filing evidence
2024-01-01 – 2024-06-301526000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-31743000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-313091000000 USD20260217Open filing evidence
2023-07-01 – 2023-09-30761000000 USD20241031Open filing evidence
2023-01-01 – 2023-09-302268000000 USD20241031Open filing evidence
2023-04-01 – 2023-06-30772000000 USD20240722Open filing evidence
2023-01-01 – 2023-06-301507000000 USD20240722Open filing evidence
2022-01-01 – 2022-12-312947000000 USD20250213Open filing evidence
2022-07-01 – 2022-09-30746000000 USD20221027Open filing evidence
2022-01-01 – 2022-09-302143000000 USD20221027Open filing evidence
2022-04-01 – 2022-06-30716000000 USD20230801Open filing evidence
2022-01-01 – 2022-06-301397000000 USD20230801Open filing evidence
2022-01-01 – 2022-03-31681000000 USD20220428Open filing evidence
2021-07-01 – 2021-09-30647000000 USD20221027Open filing evidence
2021-01-01 – 2021-09-301882000000 USD20221027Open filing evidence
2021-04-01 – 2021-06-30635000000 USD20220722Open filing evidence
2021-01-01 – 2021-06-301235000000 USD20220722Open filing evidence
2021-01-01 – 2021-03-31600000000 USD20220428Open filing evidence
2020-01-01 – 2020-12-312413000000 USD20210212Open filing evidence
2020-07-01 – 2020-09-30599000000 USD20211022Open filing evidence
2020-01-01 – 2020-09-301747000000 USD20211022Open filing evidence
2020-04-01 – 2020-06-30567000000 USD20210728Open filing evidence
2020-01-01 – 2020-06-301148000000 USD20210728Open filing evidence
2020-01-01 – 2020-03-31581000000 USD20200430Open filing evidence
2019-01-01 – 2019-12-312370000000 USD20210212Open filing evidence

Asia Pacific · Commercial Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AsiaPacificMember;us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30211000000 USD20260728Open filing evidence
2026-01-01 – 2026-03-31210000000 USD20260505Open filing evidence
2025-04-01 – 2025-06-30186000000 USD20260728Open filing evidence
2025-01-01 – 2025-03-31189000000 USD20260505Open filing evidence

Asia Pacific · Contract Sales And Medical Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AsiaPacificMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-31245000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-3064000000 USD20251028Open filing evidence
2025-01-01 – 2025-09-30182000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-3060000000 USD20250722Open filing evidence
2025-01-01 – 2025-06-30118000000 USD20250722Open filing evidence
2025-01-01 – 2025-03-3158000000 USD20250506Open filing evidence
2024-01-01 – 2024-12-31219000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-3054000000 USD20251028Open filing evidence
2024-01-01 – 2024-09-30164000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-3054000000 USD20250722Open filing evidence
2024-01-01 – 2024-06-30110000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-3156000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31223000000 USD20260217Open filing evidence
2023-07-01 – 2023-09-3055000000 USD20241031Open filing evidence
2023-01-01 – 2023-09-30167000000 USD20241031Open filing evidence
2023-04-01 – 2023-06-3057000000 USD20240722Open filing evidence
2023-01-01 – 2023-06-30112000000 USD20240722Open filing evidence
2023-01-01 – 2023-03-3155000000 USD20230428Open filing evidence
2022-01-01 – 2022-12-31214000000 USD20250213Open filing evidence
2022-07-01 – 2022-09-3052000000 USD20221027Open filing evidence
2022-01-01 – 2022-09-30162000000 USD20221027Open filing evidence
2022-01-01 – 2022-03-3158000000 USD20230428Open filing evidence
2021-01-01 – 2021-12-31257000000 USD20240215Open filing evidence
2021-07-01 – 2021-09-3065000000 USD20221027Open filing evidence
2021-01-01 – 2021-09-30197000000 USD20221027Open filing evidence
2021-04-01 – 2021-06-3066000000 USD20210728Open filing evidence
2021-01-01 – 2021-06-30132000000 USD20210728Open filing evidence
2021-01-01 – 2021-03-3166000000 USD20220428Open filing evidence
2020-01-01 – 2020-12-31231000000 USD20210212Open filing evidence
2020-07-01 – 2020-09-3059000000 USD20211022Open filing evidence
2020-01-01 – 2020-09-30171000000 USD20211022Open filing evidence
2020-04-01 – 2020-06-3057000000 USD20210728Open filing evidence
2020-01-01 – 2020-06-30112000000 USD20210728Open filing evidence
2019-01-01 – 2019-12-31215000000 USD20210212Open filing evidence

Asia Pacific · Research And Development Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AsiaPacificMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30709000000 USD20260728Open filing evidence
2026-01-01 – 2026-06-301311000000 USD20260728Open filing evidence
2026-01-01 – 2026-03-31602000000 USD20260505Open filing evidence
2025-01-01 – 2025-12-312518000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-30651000000 USD20251028Open filing evidence
2025-01-01 – 2025-09-301874000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-30655000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-06-301264000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-03-31609000000 RestatedUSD20260505Open filing evidence
2024-01-01 – 2024-12-312329000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-30586000000 USD20251028Open filing evidence
2024-01-01 – 2024-09-301736000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-30576000000 USD20250722Open filing evidence
2024-01-01 – 2024-06-301150000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-31574000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-312135000000 USD20260217Open filing evidence
2023-07-01 – 2023-09-30585000000 USD20241031Open filing evidence
2023-01-01 – 2023-09-301715000000 USD20241031Open filing evidence
2023-04-01 – 2023-06-30581000000 USD20240722Open filing evidence
2023-01-01 – 2023-06-301130000000 USD20240722Open filing evidence
2023-01-01 – 2023-03-31549000000 USD20240502Open filing evidence
2022-01-01 – 2022-12-312158000000 USD20250213Open filing evidence
2022-07-01 – 2022-09-30531000000 USD20231101Open filing evidence
2022-01-01 – 2022-09-301564000000 USD20231101Open filing evidence
2022-04-01 – 2022-06-30552000000 USD20220722Open filing evidence
2022-01-01 – 2022-06-301033000000 USD20220722Open filing evidence
2022-01-01 – 2022-03-31481000000 USD20220428Open filing evidence
2021-01-01 – 2021-12-311770000000 USD20220216Open filing evidence
2021-07-01 – 2021-09-30463000000 USD20221027Open filing evidence
2021-01-01 – 2021-09-301303000000 USD20221027Open filing evidence
2021-04-01 – 2021-06-30449000000 USD20220722Open filing evidence
2021-01-01 – 2021-06-30840000000 USD20220722Open filing evidence
2021-01-01 – 2021-03-31391000000 USD20220428Open filing evidence
2020-01-01 – 2020-12-311413000000 USD20220216Open filing evidence
2020-07-01 – 2020-09-30361000000 USD20211022Open filing evidence
2020-01-01 – 2020-09-301036000000 USD20211022Open filing evidence
2020-04-01 – 2020-06-30332000000 USD20210728Open filing evidence
2020-01-01 – 2020-06-30675000000 USD20210728Open filing evidence
2019-01-01 – 2019-12-311361000000 USD20220216Open filing evidence
2019-07-01 – 2019-09-30346000000 USD20201022Open filing evidence
2019-01-01 – 2019-09-301010000000 USD20201022Open filing evidence

Asia Pacific · Technology And Analytics Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AsiaPacificMember;us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-06-30421000000 USD20260728Open filing evidence
2025-01-01 – 2025-12-31617000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-30155000000 USD20251028Open filing evidence
2025-01-01 – 2025-09-30453000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-30152000000 USD20250722Open filing evidence
2025-01-01 – 2025-06-30375000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-03-31146000000 USD20250506Open filing evidence
2024-01-01 – 2024-12-31581000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-30131000000 USD20251028Open filing evidence
2024-01-01 – 2024-09-30422000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-30143000000 USD20250722Open filing evidence
2024-01-01 – 2024-06-30291000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-31148000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31615000000 USD20260217Open filing evidence
2023-07-01 – 2023-09-30151000000 USD20241031Open filing evidence
2023-01-01 – 2023-09-30457000000 USD20241031Open filing evidence
2023-04-01 – 2023-06-30153000000 USD20240722Open filing evidence
2023-01-01 – 2023-06-30306000000 USD20240722Open filing evidence
2022-01-01 – 2022-12-31624000000 USD20250213Open filing evidence
2022-07-01 – 2022-09-30151000000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30465000000 USD20231101Open filing evidence
2022-04-01 – 2022-06-30152000000 USD20220722Open filing evidence
2022-01-01 – 2022-06-30314000000 USD20220722Open filing evidence
2022-01-01 – 2022-03-31162000000 USD20220428Open filing evidence
2021-01-01 – 2021-12-31642000000 USD20240215Open filing evidence
2021-07-01 – 2021-09-30161000000 USD20221027Open filing evidence
2021-01-01 – 2021-09-30472000000 USD20221027Open filing evidence
2021-04-01 – 2021-06-30153000000 USD20220722Open filing evidence
2021-01-01 – 2021-06-30311000000 USD20220722Open filing evidence
2021-01-01 – 2021-03-31158000000 USD20220428Open filing evidence
2020-01-01 – 2020-12-31601000000 USD20210212Open filing evidence
2020-07-01 – 2020-09-30151000000 USD20211022Open filing evidence
2020-01-01 – 2020-09-30432000000 USD20211022Open filing evidence
2020-04-01 – 2020-06-30141000000 USD20210728Open filing evidence
2020-01-01 – 2020-06-30281000000 USD20210728Open filing evidence
2020-01-01 – 2020-03-31140000000 USD20200430Open filing evidence
2019-01-01 – 2019-12-31573000000 USD20210212Open filing evidence
2019-07-01 – 2019-09-30146000000 USD20201022Open filing evidence
2019-01-01 – 2019-09-30422000000 USD20201022Open filing evidence
2019-01-01 – 2019-06-30276000000 USD20200723Open filing evidence

EMEA · Commercial Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=us-gaap:EMEAMember;us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30687000000 USD20260728Open filing evidence
2026-01-01 – 2026-03-31688000000 USD20260505Open filing evidence
2025-04-01 – 2025-06-30640000000 USD20260728Open filing evidence
2025-01-01 – 2025-03-31593000000 USD20260505Open filing evidence

EMEA · Contract Sales And Medical Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=us-gaap:EMEAMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-31266000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-3075000000 USD20251028Open filing evidence
2025-01-01 – 2025-09-30188000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-3060000000 USD20250722Open filing evidence
2025-01-01 – 2025-06-30113000000 USD20250722Open filing evidence
2025-01-01 – 2025-03-3153000000 USD20250506Open filing evidence
2024-01-01 – 2024-12-31219000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-3054000000 USD20251028Open filing evidence
2024-01-01 – 2024-09-30166000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-3052000000 USD20250722Open filing evidence
2024-01-01 – 2024-06-30112000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-3160000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31200000000 USD20260217Open filing evidence
2023-07-01 – 2023-09-3050000000 USD20241031Open filing evidence
2023-01-01 – 2023-09-30146000000 USD20241031Open filing evidence
2023-04-01 – 2023-06-3049000000 USD20240722Open filing evidence
2023-01-01 – 2023-06-3096000000 USD20240722Open filing evidence
2023-01-01 – 2023-03-3147000000 USD20230428Open filing evidence
2022-01-01 – 2022-12-31175000000 USD20250213Open filing evidence
2022-07-01 – 2022-09-3040000000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30129000000 USD20231101Open filing evidence
2022-04-01 – 2022-06-3043000000 USD20220722Open filing evidence
2022-01-01 – 2022-06-3089000000 USD20220722Open filing evidence
2022-01-01 – 2022-03-3146000000 USD20230428Open filing evidence
2021-01-01 – 2021-12-31176000000 USD20240215Open filing evidence
2021-07-01 – 2021-09-3042000000 USD20211022Open filing evidence
2021-01-01 – 2021-09-30133000000 USD20211022Open filing evidence
2021-04-01 – 2021-06-3042000000 USD20220722Open filing evidence
2021-01-01 – 2021-06-3091000000 USD20220722Open filing evidence
2021-01-01 – 2021-03-3149000000 USD20220428Open filing evidence
2020-01-01 – 2020-12-31184000000 USD20220216Open filing evidence
2020-07-01 – 2020-09-3044000000 USD20211022Open filing evidence
2020-01-01 – 2020-09-30134000000 USD20211022Open filing evidence
2020-04-01 – 2020-06-3040000000 USD20210728Open filing evidence
2020-01-01 – 2020-06-3090000000 USD20210728Open filing evidence
2019-01-01 – 2019-12-31200000000 USD20220216Open filing evidence

EMEA · Research And Development Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=us-gaap:EMEAMember;us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30722000000 USD20260728Open filing evidence
2026-01-01 – 2026-06-301389000000 USD20260728Open filing evidence
2026-01-01 – 2026-03-31667000000 USD20260505Open filing evidence
2025-01-01 – 2025-12-312273000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-30570000000 USD20251028Open filing evidence
2025-01-01 – 2025-09-301659000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-30601000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-06-301232000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-03-31631000000 RestatedUSD20260505Open filing evidence
2024-01-01 – 2024-12-312304000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-30607000000 USD20251028Open filing evidence
2024-01-01 – 2024-09-301699000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-30557000000 USD20250722Open filing evidence
2024-01-01 – 2024-06-301092000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-31535000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-312103000000 USD20260217Open filing evidence
2023-07-01 – 2023-09-30520000000 USD20241031Open filing evidence
2023-01-01 – 2023-09-301547000000 USD20241031Open filing evidence
2023-04-01 – 2023-06-30536000000 USD20240722Open filing evidence
2023-01-01 – 2023-06-301027000000 USD20240722Open filing evidence
2023-01-01 – 2023-03-31491000000 USD20240502Open filing evidence
2022-01-01 – 2022-12-312016000000 USD20250213Open filing evidence
2022-07-01 – 2022-09-30488000000 USD20231101Open filing evidence
2022-01-01 – 2022-09-301527000000 USD20231101Open filing evidence
2022-04-01 – 2022-06-30532000000 USD20230801Open filing evidence
2022-01-01 – 2022-06-301039000000 USD20230801Open filing evidence
2021-01-01 – 2021-12-311899000000 USD20230215Open filing evidence
2021-04-01 – 2021-06-30507000000 USD20220722Open filing evidence
2021-01-01 – 2021-06-30950000000 USD20220722Open filing evidence
2020-01-01 – 2020-12-311667000000 USD20230215Open filing evidence
2020-07-01 – 2020-09-30411000000 USD20201022Open filing evidence
2020-01-01 – 2020-09-301214000000 USD20201022Open filing evidence
2020-04-01 – 2020-06-30375000000 USD20210728Open filing evidence
2020-01-01 – 2020-06-30803000000 USD20210728Open filing evidence
2019-01-01 – 2019-12-311734000000 USD20220216Open filing evidence
2019-07-01 – 2019-09-30394000000 USD20201022Open filing evidence
2019-01-01 – 2019-09-301298000000 USD20201022Open filing evidence

EMEA · Technology And Analytics Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=us-gaap:EMEAMember;us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-06-301375000000 USD20260728Open filing evidence
2025-01-01 – 2025-12-312646000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-30652000000 USD20251028Open filing evidence
2025-01-01 – 2025-09-301915000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-30646000000 USD20250722Open filing evidence
2025-01-01 – 2025-06-301233000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-03-31617000000 USD20250506Open filing evidence
2024-01-01 – 2024-12-312397000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-30626000000 USD20251028Open filing evidence
2024-01-01 – 2024-09-301757000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-30569000000 USD20250722Open filing evidence
2024-01-01 – 2024-06-301131000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-31562000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-312156000000 USD20260217Open filing evidence
2023-07-01 – 2023-09-30519000000 USD20241031Open filing evidence
2023-01-01 – 2023-09-301606000000 USD20241031Open filing evidence
2023-04-01 – 2023-06-30531000000 USD20240722Open filing evidence
2023-01-01 – 2023-06-301087000000 USD20240722Open filing evidence
2023-01-01 – 2023-03-31556000000 USD20240502Open filing evidence
2022-01-01 – 2022-12-312175000000 USD20250213Open filing evidence
2022-07-01 – 2022-09-30503000000 USD20231101Open filing evidence
2022-01-01 – 2022-09-301639000000 USD20231101Open filing evidence
2022-04-01 – 2022-06-30540000000 USD20230801Open filing evidence
2022-01-01 – 2022-06-301136000000 USD20230801Open filing evidence
2021-01-01 – 2021-12-312282000000 USD20230215Open filing evidence
2021-07-01 – 2021-09-30529000000 USD20211022Open filing evidence
2021-01-01 – 2021-09-301684000000 USD20211022Open filing evidence
2021-04-01 – 2021-06-30565000000 USD20220722Open filing evidence
2021-01-01 – 2021-06-301155000000 USD20220722Open filing evidence
2020-01-01 – 2020-12-311844000000 USD20230215Open filing evidence
2020-07-01 – 2020-09-30457000000 USD20211022Open filing evidence
2020-01-01 – 2020-09-301254000000 USD20211022Open filing evidence
2020-04-01 – 2020-06-30401000000 USD20210728Open filing evidence
2020-01-01 – 2020-06-30797000000 USD20210728Open filing evidence
2020-01-01 – 2020-03-31396000000 USD20200430Open filing evidence
2019-01-01 – 2019-12-311543000000 USD20220216Open filing evidence
2019-07-01 – 2019-09-30369000000 USD20201022Open filing evidence
2019-01-01 – 2019-09-301128000000 USD20201022Open filing evidence

Commercial Solutions

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-301789000000 USD20261027Open filing evidence
2026-04-01 – 2026-06-301793000000 USD20260728Open filing evidence
2026-01-01 – 2026-03-311754000000 USD20260505Open filing evidence
2025-07-01 – 2025-09-301673000000 USD20261027Open filing evidence
2025-04-01 – 2025-06-301651000000 USD20260728Open filing evidence
2025-01-01 – 2025-03-311572000000 USD20260505Open filing evidence

Commercial Solutions · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-301789000000 USD20261027Open filing evidence
2025-07-01 – 2025-09-301673000000 USD20261027Open filing evidence

Commercial Solutions · Americas

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember;srt:StatementGeographicalAxis=srt:AmericasMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30894000000 USD20261027Open filing evidence
2025-07-01 – 2025-09-30821000000 USD20261027Open filing evidence

Commercial Solutions · Asia Pacific

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember;srt:StatementGeographicalAxis=srt:AsiaPacificMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30217000000 USD20261027Open filing evidence
2025-07-01 – 2025-09-30197000000 USD20261027Open filing evidence

Commercial Solutions · EMEA

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:CommercialSolutionsMember;srt:StatementGeographicalAxis=us-gaap:EMEAMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30678000000 USD20261027Open filing evidence
2025-07-01 – 2025-09-30655000000 USD20261027Open filing evidence

Contract Sales And Medical Solutions

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-31788000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-30209000000 USD20251028Open filing evidence
2025-01-01 – 2025-09-30578000000 USD20251028Open filing evidence
2025-04-01 – 2025-06-30188000000 USD20250722Open filing evidence
2025-01-01 – 2025-06-30369000000 USD20250722Open filing evidence
2025-01-01 – 2025-03-31181000000 USD20250506Open filing evidence
2024-01-01 – 2024-12-31718000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-30180000000 USD20251028Open filing evidence
2024-01-01 – 2024-09-30541000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-30172000000 USD20250722Open filing evidence
2024-01-01 – 2024-06-30361000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-31189000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31727000000 USD20260217Open filing evidence
2023-07-01 – 2023-09-30183000000 USD20241031Open filing evidence
2023-01-01 – 2023-09-30541000000 USD20241031Open filing evidence
2023-04-01 – 2023-06-30176000000 USD20240722Open filing evidence
2023-01-01 – 2023-06-30358000000 USD20240722Open filing evidence
2023-01-01 – 2023-03-31182000000 USD20240502Open filing evidence
2022-01-01 – 2022-12-31743000000 USD20250213Open filing evidence
2022-07-01 – 2022-09-30183000000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30561000000 USD20231101Open filing evidence
2022-04-01 – 2022-06-30183000000 USD20230801Open filing evidence
2022-01-01 – 2022-06-30378000000 USD20230801Open filing evidence
2022-01-01 – 2022-03-31195000000 USD20230428Open filing evidence
2021-01-01 – 2021-12-31784000000 USD20240215Open filing evidence
2021-07-01 – 2021-09-30201000000 USD20221027Open filing evidence
2021-01-01 – 2021-09-30588000000 USD20221027Open filing evidence
2021-04-01 – 2021-06-30194000000 USD20220722Open filing evidence
2021-01-01 – 2021-06-30387000000 USD20220722Open filing evidence
2021-01-01 – 2021-03-31193000000 USD20220428Open filing evidence
2020-01-01 – 2020-12-31741000000 USD20230215Open filing evidence
2020-07-01 – 2020-09-30179000000 USD20211022Open filing evidence
2020-01-01 – 2020-09-30552000000 USD20211022Open filing evidence
2020-04-01 – 2020-06-30177000000 USD20210728Open filing evidence
2020-01-01 – 2020-06-30373000000 USD20210728Open filing evidence
2020-01-01 – 2020-03-31196000000 USD20210423Open filing evidence
2019-01-01 – 2019-12-31814000000 USD20220216Open filing evidence
2019-07-01 – 2019-09-30208000000 USD20201022Open filing evidence
2019-01-01 – 2019-09-30604000000 USD20201022Open filing evidence

Contract Sales And Medical Solutions · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31727000000 USD20240215Open filing evidence
2022-01-01 – 2022-12-31743000000 USD20240215Open filing evidence
2021-01-01 – 2021-12-31784000000 USD20240215Open filing evidence
2020-01-01 – 2020-12-31741000000 USD20220216Open filing evidence
2020-01-01 – 2020-03-31196000000 USD20200430Open filing evidence
2019-01-01 – 2019-12-31814000000 USD20220216Open filing evidence

Contract Sales And Medical Solutions · Americas

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember;srt:StatementGeographicalAxis=srt:AmericasMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-3173000000 USD20240502Open filing evidence
2023-01-01 – 2023-12-31304000000 USD20240215Open filing evidence
2023-07-01 – 2023-09-3078000000 USD20231101Open filing evidence
2023-01-01 – 2023-09-30228000000 USD20231101Open filing evidence
2023-01-01 – 2023-03-3180000000 USD20240502Open filing evidence
2022-01-01 – 2022-12-31354000000 USD20240215Open filing evidence
2022-07-01 – 2022-09-3091000000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30270000000 USD20231101Open filing evidence
2021-01-01 – 2021-12-31351000000 USD20240215Open filing evidence
2021-07-01 – 2021-09-3094000000 USD20221027Open filing evidence
2021-01-01 – 2021-09-30258000000 USD20221027Open filing evidence
2021-01-01 – 2021-03-3178000000 USD20210423Open filing evidence
2020-01-01 – 2020-12-31326000000 USD20230215Open filing evidence
2020-07-01 – 2020-09-3076000000 USD20201022Open filing evidence
2020-01-01 – 2020-09-30247000000 USD20201022Open filing evidence
2020-04-01 – 2020-06-3080000000 USD20200723Open filing evidence
2020-01-01 – 2020-06-30171000000 USD20200723Open filing evidence
2020-01-01 – 2020-03-3191000000 USD20210423Open filing evidence
2019-01-01 – 2019-12-31399000000 USD20220216Open filing evidence
2019-07-01 – 2019-09-30104000000 USD20201022Open filing evidence
2019-01-01 – 2019-09-30298000000 USD20201022Open filing evidence

Contract Sales And Medical Solutions · Asia Pacific

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember;srt:StatementGeographicalAxis=srt:AsiaPacificMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-3156000000 USD20240502Open filing evidence
2023-07-01 – 2023-09-3055000000 USD20231101Open filing evidence
2023-01-01 – 2023-09-30167000000 USD20231101Open filing evidence
2023-04-01 – 2023-06-3057000000 USD20230801Open filing evidence
2023-01-01 – 2023-06-30112000000 USD20230801Open filing evidence
2023-01-01 – 2023-03-3155000000 USD20240502Open filing evidence
2022-01-01 – 2022-12-31214000000 USD20230215Open filing evidence
2022-07-01 – 2022-09-3052000000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30162000000 USD20231101Open filing evidence
2022-04-01 – 2022-06-3052000000 USD20230801Open filing evidence
2022-01-01 – 2022-06-30110000000 USD20230801Open filing evidence
2021-01-01 – 2021-12-31257000000 USD20230215Open filing evidence
2021-04-01 – 2021-06-3066000000 USD20220722Open filing evidence
2021-01-01 – 2021-06-30132000000 USD20220722Open filing evidence
2021-01-01 – 2021-03-3166000000 USD20210423Open filing evidence
2020-01-01 – 2020-12-31231000000 USD20230215Open filing evidence
2020-07-01 – 2020-09-3059000000 USD20201022Open filing evidence
2020-01-01 – 2020-09-30171000000 USD20201022Open filing evidence
2020-04-01 – 2020-06-3057000000 USD20200723Open filing evidence
2020-01-01 – 2020-06-30112000000 USD20200723Open filing evidence
2020-01-01 – 2020-03-3155000000 USD20210423Open filing evidence
2019-01-01 – 2019-12-31215000000 USD20220216Open filing evidence
2019-07-01 – 2019-09-3056000000 USD20201022Open filing evidence
2019-01-01 – 2019-09-30158000000 USD20201022Open filing evidence

Contract Sales And Medical Solutions · EMEA

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:ContractSalesAndMedicalSolutionsMember;srt:StatementGeographicalAxis=us-gaap:EMEAMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-3160000000 USD20240502Open filing evidence
2023-04-01 – 2023-06-3049000000 USD20230801Open filing evidence
2023-01-01 – 2023-06-3096000000 USD20230801Open filing evidence
2023-01-01 – 2023-03-3147000000 USD20240502Open filing evidence
2022-01-01 – 2022-12-31175000000 USD20230215Open filing evidence
2022-07-01 – 2022-09-3040000000 USD20221027Open filing evidence
2022-01-01 – 2022-09-30129000000 USD20221027Open filing evidence
2022-04-01 – 2022-06-3043000000 USD20230801Open filing evidence
2022-01-01 – 2022-06-3089000000 USD20230801Open filing evidence
2021-01-01 – 2021-12-31176000000 USD20230215Open filing evidence
2021-07-01 – 2021-09-3042000000 USD20221027Open filing evidence
2021-01-01 – 2021-09-30133000000 USD20221027Open filing evidence
2021-01-01 – 2021-03-3149000000 USD20210423Open filing evidence
2020-01-01 – 2020-12-31184000000 USD20230215Open filing evidence
2020-07-01 – 2020-09-3044000000 USD20201022Open filing evidence
2020-01-01 – 2020-09-30134000000 USD20201022Open filing evidence
2020-04-01 – 2020-06-3040000000 USD20200723Open filing evidence
2020-01-01 – 2020-06-3090000000 USD20200723Open filing evidence
2020-01-01 – 2020-03-3150000000 USD20210423Open filing evidence
2019-01-01 – 2019-12-31200000000 USD20200218Open filing evidence
2019-07-01 – 2019-09-3048000000 USD20201022Open filing evidence
2019-01-01 – 2019-09-30148000000 USD20201022Open filing evidence

Research And Development Solutions

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-302639000000 USD20261027Open filing evidence
2026-01-01 – 2026-09-307611000000 USD20261027Open filing evidence
2026-04-01 – 2026-06-302575000000 USD20260728Open filing evidence
2026-01-01 – 2026-06-304972000000 USD20260728Open filing evidence
2026-01-01 – 2026-03-312397000000 USD20260505Open filing evidence
2025-01-01 – 2025-12-318896000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-302427000000 RestatedUSD20261027Open filing evidence
2025-01-01 – 2025-09-307050000000 RestatedUSD20261027Open filing evidence
2025-04-01 – 2025-06-302366000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-06-304623000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-03-312257000000 RestatedUSD20260505Open filing evidence
2024-01-01 – 2024-12-318527000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-302162000000 USD20251028Open filing evidence
2024-01-01 – 2024-09-306404000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-302147000000 USD20250722Open filing evidence
2024-01-01 – 2024-06-304242000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-312095000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-318395000000 USD20260217Open filing evidence
2023-07-01 – 2023-09-302122000000 USD20241031Open filing evidence
2023-01-01 – 2023-09-306244000000 USD20241031Open filing evidence
2023-04-01 – 2023-06-302096000000 USD20240722Open filing evidence
2023-01-01 – 2023-06-304122000000 USD20240722Open filing evidence
2023-01-01 – 2023-03-312026000000 USD20240502Open filing evidence
2022-01-01 – 2022-12-317921000000 USD20250213Open filing evidence
2022-07-01 – 2022-09-301979000000 USD20231101Open filing evidence
2022-01-01 – 2022-09-305863000000 USD20231101Open filing evidence
2022-04-01 – 2022-06-301950000000 USD20230801Open filing evidence
2022-01-01 – 2022-06-303884000000 USD20230801Open filing evidence
2022-01-01 – 2022-03-311934000000 USD20230428Open filing evidence
2021-01-01 – 2021-12-317556000000 USD20240215Open filing evidence
2021-07-01 – 2021-09-301853000000 USD20221027Open filing evidence
2021-01-01 – 2021-09-305612000000 USD20221027Open filing evidence
2021-04-01 – 2021-06-301891000000 USD20220722Open filing evidence
2021-01-01 – 2021-06-303759000000 USD20220722Open filing evidence
2021-01-01 – 2021-03-311868000000 USD20220428Open filing evidence
2020-01-01 – 2020-12-315760000000 USD20230215Open filing evidence
2020-07-01 – 2020-09-301400000000 USD20211022Open filing evidence
2020-01-01 – 2020-09-304076000000 USD20211022Open filing evidence
2020-04-01 – 2020-06-301235000000 USD20210728Open filing evidence
2020-01-01 – 2020-06-302676000000 USD20210728Open filing evidence
2020-01-01 – 2020-03-311441000000 USD20210423Open filing evidence
2019-01-01 – 2019-12-315788000000 USD20220216Open filing evidence
2019-07-01 – 2019-09-301466000000 USD20201022Open filing evidence
2019-01-01 – 2019-09-304317000000 USD20201022Open filing evidence

Research And Development Solutions · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-302639000000 USD20261027Open filing evidence
2025-07-01 – 2025-09-302427000000 USD20261027Open filing evidence
2023-01-01 – 2023-12-318395000000 USD20240215Open filing evidence
2022-01-01 – 2022-12-317921000000 USD20240215Open filing evidence
2021-01-01 – 2021-12-317556000000 USD20240215Open filing evidence
2020-01-01 – 2020-03-311441000000 USD20200430Open filing evidence

Research And Development Solutions · Americas

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember;srt:StatementGeographicalAxis=srt:AmericasMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-301193000000 USD20261027Open filing evidence
2026-01-01 – 2026-09-303465000000 USD20261027Open filing evidence
2025-07-01 – 2025-09-301112000000 USD20261027Open filing evidence
2025-01-01 – 2025-09-303239000000 USD20261027Open filing evidence
2024-04-01 – 2024-06-301014000000 USD20240722Open filing evidence
2024-01-01 – 2024-06-302000000000 USD20240722Open filing evidence
2023-01-01 – 2023-12-314157000000 USD20240215Open filing evidence
2023-07-01 – 2023-09-301017000000 USD20231101Open filing evidence
2023-01-01 – 2023-09-302982000000 USD20231101Open filing evidence
2023-04-01 – 2023-06-30979000000 USD20240722Open filing evidence
2023-01-01 – 2023-06-301965000000 USD20240722Open filing evidence
2023-01-01 – 2023-03-31986000000 USD20230428Open filing evidence
2022-01-01 – 2022-12-313747000000 USD20240215Open filing evidence
2022-07-01 – 2022-09-30960000000 USD20231101Open filing evidence
2022-01-01 – 2022-09-302772000000 USD20231101Open filing evidence
2022-01-01 – 2022-03-31946000000 USD20230428Open filing evidence
2021-01-01 – 2021-12-313887000000 USD20240215Open filing evidence
2021-01-01 – 2021-03-311034000000 USD20210423Open filing evidence
2020-04-01 – 2020-06-30528000000 USD20200723Open filing evidence
2020-01-01 – 2020-06-301198000000 USD20200723Open filing evidence
2020-01-01 – 2020-03-31670000000 USD20210423Open filing evidence
2019-01-01 – 2019-12-312693000000 USD20200218Open filing evidence
2019-07-01 – 2019-09-30726000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence
2019-01-01 – 2019-09-302009000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence

Research And Development Solutions · Asia Pacific

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember;srt:StatementGeographicalAxis=srt:AsiaPacificMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30707000000 USD20261027Open filing evidence
2026-01-01 – 2026-09-302018000000 USD20261027Open filing evidence
2025-07-01 – 2025-09-30673000000 USD20261027Open filing evidence
2025-01-01 – 2025-09-301937000000 USD20261027Open filing evidence
2023-01-01 – 2023-12-312135000000 USD20240215Open filing evidence
2023-04-01 – 2023-06-30581000000 USD20230801Open filing evidence
2023-01-01 – 2023-06-301130000000 USD20230801Open filing evidence
2023-01-01 – 2023-03-31549000000 USD20230428Open filing evidence
2022-01-01 – 2022-12-312158000000 USD20240215Open filing evidence
2022-04-01 – 2022-06-30552000000 USD20230801Open filing evidence
2022-01-01 – 2022-06-301033000000 USD20230801Open filing evidence
2022-01-01 – 2022-03-31481000000 USD20230428Open filing evidence
2021-01-01 – 2021-12-311770000000 USD20240215Open filing evidence
2021-01-01 – 2021-03-31391000000 USD20210423Open filing evidence
2020-01-01 – 2020-12-311413000000 USD20230215Open filing evidence
2020-04-01 – 2020-06-30332000000 USD20200723Open filing evidence
2020-01-01 – 2020-06-30675000000 USD20200723Open filing evidence
2020-01-01 – 2020-03-31343000000 USD20210423Open filing evidence
2019-01-01 – 2019-12-311361000000 USD20200218Open filing evidence
2019-07-01 – 2019-09-30346000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence
2019-01-01 – 2019-09-301010000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence

Research And Development Solutions · EMEA

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:ResearchAndDevelopmentSolutionsMember;srt:StatementGeographicalAxis=us-gaap:EMEAMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30739000000 USD20261027Open filing evidence
2026-01-01 – 2026-09-302128000000 USD20261027Open filing evidence
2025-07-01 – 2025-09-30642000000 USD20261027Open filing evidence
2025-01-01 – 2025-09-301874000000 USD20261027Open filing evidence
2023-01-01 – 2023-12-312103000000 USD20240215Open filing evidence
2023-01-01 – 2023-03-31491000000 USD20230428Open filing evidence
2022-01-01 – 2022-12-312016000000 USD20240215Open filing evidence
2022-07-01 – 2022-09-30488000000 USD20221027Open filing evidence
2022-01-01 – 2022-09-301527000000 USD20221027Open filing evidence
2022-01-01 – 2022-03-31507000000 USD20230428Open filing evidence
2021-01-01 – 2021-12-311899000000 USD20240215Open filing evidence
2021-07-01 – 2021-09-30448000000 USD20221027Open filing evidence
2021-01-01 – 2021-09-301398000000 USD20221027Open filing evidence
2021-01-01 – 2021-03-31443000000 USD20220428Open filing evidence
2020-07-01 – 2020-09-30411000000 USD20211022Open filing evidence
2020-01-01 – 2020-09-301214000000 USD20211022Open filing evidence
2020-04-01 – 2020-06-30375000000 USD20200723Open filing evidence
2020-01-01 – 2020-06-30803000000 USD20200723Open filing evidence
2020-01-01 – 2020-03-31428000000 USD20210423Open filing evidence
2019-01-01 – 2019-12-311734000000 USD20200218Open filing evidence
2019-07-01 – 2019-09-30394000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence
2019-01-01 – 2019-09-301298000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence

Technology And Analytics Solutions

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-305336000000 USD20261027Open filing evidence
2026-01-01 – 2026-06-303547000000 USD20260728Open filing evidence
2025-01-01 – 2025-12-316626000000 USD20260217Open filing evidence
2025-07-01 – 2025-09-301631000000 USD20251028Open filing evidence
2025-01-01 – 2025-09-304896000000 RestatedUSD20261027Open filing evidence
2025-04-01 – 2025-06-301628000000 USD20250722Open filing evidence
2025-01-01 – 2025-06-303223000000 RestatedUSD20260728Open filing evidence
2025-01-01 – 2025-03-311546000000 USD20250506Open filing evidence
2024-01-01 – 2024-12-316160000000 USD20260217Open filing evidence
2024-07-01 – 2024-09-301554000000 USD20251028Open filing evidence
2024-01-01 – 2024-09-304502000000 USD20251028Open filing evidence
2024-04-01 – 2024-06-301495000000 USD20250722Open filing evidence
2024-01-01 – 2024-06-302948000000 USD20250722Open filing evidence
2024-01-01 – 2024-03-311453000000 USD20250506Open filing evidence
2023-01-01 – 2023-12-315862000000 USD20260217Open filing evidence
2023-07-01 – 2023-09-301431000000 USD20241031Open filing evidence
2023-01-01 – 2023-09-304331000000 USD20241031Open filing evidence
2023-04-01 – 2023-06-301456000000 USD20240722Open filing evidence
2023-01-01 – 2023-06-302900000000 USD20240722Open filing evidence
2023-01-01 – 2023-03-311444000000 USD20240502Open filing evidence
2022-01-01 – 2022-12-315746000000 USD20250213Open filing evidence
2022-07-01 – 2022-09-301400000000 USD20231101Open filing evidence
2022-01-01 – 2022-09-304247000000 USD20231101Open filing evidence
2022-04-01 – 2022-06-301408000000 USD20230801Open filing evidence
2022-01-01 – 2022-06-302847000000 USD20230801Open filing evidence
2022-01-01 – 2022-03-311439000000 USD20230428Open filing evidence
2021-01-01 – 2021-12-315534000000 USD20240215Open filing evidence
2021-07-01 – 2021-09-301337000000 USD20221027Open filing evidence
2021-01-01 – 2021-09-304038000000 USD20221027Open filing evidence
2021-04-01 – 2021-06-301353000000 USD20220722Open filing evidence
2021-01-01 – 2021-06-302701000000 USD20220722Open filing evidence
2021-01-01 – 2021-03-311348000000 USD20220428Open filing evidence
2020-01-01 – 2020-12-314858000000 USD20230215Open filing evidence
2020-07-01 – 2020-09-301207000000 USD20211022Open filing evidence
2020-01-01 – 2020-09-303433000000 USD20211022Open filing evidence
2020-04-01 – 2020-06-301109000000 USD20210728Open filing evidence
2020-01-01 – 2020-06-302226000000 USD20210728Open filing evidence
2020-01-01 – 2020-03-311117000000 USD20210423Open filing evidence
2019-01-01 – 2019-12-314486000000 USD20220216Open filing evidence
2019-07-01 – 2019-09-301095000000 USD20201022Open filing evidence
2019-01-01 – 2019-09-303272000000 USD20201022Open filing evidence

Technology And Analytics Solutions · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-315862000000 USD20240215Open filing evidence
2022-01-01 – 2022-12-315746000000 USD20240215Open filing evidence
2021-01-01 – 2021-12-315534000000 USD20240215Open filing evidence
2020-01-01 – 2020-12-314858000000 USD20220216Open filing evidence
2019-01-01 – 2019-12-314486000000 USD20220216Open filing evidence

Technology And Analytics Solutions · Americas

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember;srt:StatementGeographicalAxis=srt:AmericasMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-302645000000 USD20261027Open filing evidence
2025-01-01 – 2025-09-302436000000 USD20261027Open filing evidence
2024-01-01 – 2024-03-31743000000 USD20240502Open filing evidence
2023-01-01 – 2023-12-313091000000 USD20240215Open filing evidence
2023-07-01 – 2023-09-30761000000 USD20231101Open filing evidence
2023-01-01 – 2023-09-302268000000 USD20231101Open filing evidence
2023-01-01 – 2023-03-31735000000 USD20240502Open filing evidence
2022-01-01 – 2022-12-312947000000 USD20240215Open filing evidence
2022-07-01 – 2022-09-30746000000 USD20231101Open filing evidence
2022-01-01 – 2022-09-302143000000 USD20231101Open filing evidence
2022-01-01 – 2022-03-31681000000 USD20230428Open filing evidence
2021-01-01 – 2021-12-312610000000 USD20240215Open filing evidence
2021-01-01 – 2021-03-31600000000 USD20210423Open filing evidence
2020-01-01 – 2020-12-312413000000 USD20230215Open filing evidence
2020-07-01 – 2020-09-30599000000 USD20201022Open filing evidence
2020-01-01 – 2020-09-301747000000 USD20201022Open filing evidence
2020-04-01 – 2020-06-30567000000 USD20200723Open filing evidence
2020-01-01 – 2020-06-301148000000 USD20200723Open filing evidence
2020-01-01 – 2020-03-31581000000 USD20210423Open filing evidence
2019-01-01 – 2019-12-312370000000 USD20220216Open filing evidence
2019-07-01 – 2019-09-30580000000 USD20201022Open filing evidence
2019-01-01 – 2019-09-301722000000 USD20201022Open filing evidence

Technology And Analytics Solutions · Asia Pacific

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember;srt:StatementGeographicalAxis=srt:AsiaPacificMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-30638000000 USD20261027Open filing evidence
2025-01-01 – 2025-09-30572000000 USD20261027Open filing evidence
2024-01-01 – 2024-03-31148000000 USD20240502Open filing evidence
2023-04-01 – 2023-06-30153000000 USD20230801Open filing evidence
2023-01-01 – 2023-06-30306000000 USD20230801Open filing evidence
2023-01-01 – 2023-03-31153000000 USD20240502Open filing evidence
2022-01-01 – 2022-12-31624000000 USD20230215Open filing evidence
2022-04-01 – 2022-06-30152000000 USD20230801Open filing evidence
2022-01-01 – 2022-06-30314000000 USD20230801Open filing evidence
2022-01-01 – 2022-03-31162000000 USD20230428Open filing evidence
2021-01-01 – 2021-12-31642000000 USD20230215Open filing evidence
2021-01-01 – 2021-03-31158000000 USD20210423Open filing evidence
2020-01-01 – 2020-12-31601000000 USD20230215Open filing evidence
2020-01-01 – 2020-03-31140000000 USD20210423Open filing evidence
2019-01-01 – 2019-12-31573000000 USD20220216Open filing evidence
2019-07-01 – 2019-09-30146000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence
2019-01-01 – 2019-09-30422000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence

Technology And Analytics Solutions · EMEA

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iqv:TechnologyAndAnalyticsSolutionsMember;srt:StatementGeographicalAxis=us-gaap:EMEAMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-302053000000 USD20261027Open filing evidence
2025-01-01 – 2025-09-301888000000 USD20261027Open filing evidence
2023-01-01 – 2023-12-312156000000 USD20240215Open filing evidence
2023-01-01 – 2023-03-31556000000 USD20230428Open filing evidence
2022-01-01 – 2022-12-312175000000 USD20240215Open filing evidence
2022-07-01 – 2022-09-30503000000 USD20221027Open filing evidence
2022-01-01 – 2022-09-301639000000 USD20221027Open filing evidence
2022-01-01 – 2022-03-31596000000 USD20230428Open filing evidence
2021-01-01 – 2021-12-312282000000 USD20240215Open filing evidence
2021-07-01 – 2021-09-30529000000 USD20221027Open filing evidence
2021-01-01 – 2021-09-301684000000 USD20221027Open filing evidence
2021-01-01 – 2021-03-31590000000 USD20220428Open filing evidence
2020-04-01 – 2020-06-30401000000 USD20200723Open filing evidence
2020-01-01 – 2020-06-30797000000 USD20200723Open filing evidence
2020-01-01 – 2020-03-31396000000 USD20210423Open filing evidence
2019-01-01 – 2019-12-311543000000 USD20200218Open filing evidence
2019-07-01 – 2019-09-30369000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence
2019-01-01 – 2019-09-301128000000 USD2019-11-01 · 11:26:08.000ZOpen filing evidence